Loading clinical trials...
Loading clinical trials...
Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer in 2 Centers in Asyut
To evaluate clinical and pathological characteristics and treatment protocol and outcomes of patients with prostate cancer in 2 centers of Asyut from 2013 to 2023
Inclusion criteria : * Male patient , Age ≥ 40 yo * Diagnosed as prostate cancer from ( 2013- 2023 ) proved by biopsy in South Egypt Cancer Institute "SECI" \& Asyut clinical oncology department * Newly diagnosed/ metastatic at presentation * ECOG 0-4 • Exclusion criteria: * Having Other types of malignancy.
Age
40 - No limit years
Sex
MALE
Healthy Volunteers
No
Start Date
January 1, 2023
Primary Completion Date
March 1, 2024
Completion Date
April 1, 2024
Last Updated
January 19, 2023
100
ESTIMATED participants
Radiotherapy
RADIATION
Lead Sponsor
Assiut University
NCT04550494
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions